The West Yorkshire, UK-based firm says the system runs from one cylinder of mixed gas and there are separate cycles to prepare anaerobic or microaerobic conditions. It takes less than two minutes and about 18p to create an anaerobic environment, and just 15 seconds and less than 3p to achieve microaerobic conditions.
According to the company, laboratories with low sample throughput can justify this system as a compact and cost-effective alternative to a workstation.
Using the Whitley jar gassing system also eliminates chemical waste and reduces condensation so that samples can be handled and read more easily following incubation, the company says.
Optional accessories include adaptor kits for reusing existing anaerobic jars.
Jar gassing system gains a colour touch screen
And an optional printer for traceability, auditing and accreditation
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
Read moreThe new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Trending Articles
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing
Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform
The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Manufacturing
FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing
A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain